UMBC research team awarded grant to innovate anti-malarial drug production

Corporate and Foundation Relations

Institutional Group • 2 people

UMBC research team awarded grant to innovate anti-malarial drug production

Corporate and Foundation Relations

July 23, 2018 at 12:00 PM

A team of researchers from UMBC is developing a new, low-cost anti-malarial drug to help tackle a disease that causes over 200 million infections and 400,000 deaths annually, according to the World Health Organization (WHO).

Visit Website

Recent Posts

UMBC and Morgan Stanley support students and research in data-intensive computing fields

Posted about 7 years ago
UMBC connects thousands of students with top employers, from Google to GM

Posted over 7 years ago
IBM-UMBC Day focuses on research collaboration in advanced computing

Posted almost 8 years ago
UMBC Center for Cybersecurity receives funding from T. Rowe Price to support students

Posted almost 8 years ago
UMBC receives $1.3 million grant from the Alfred P. Sloan Foundation to diversify economics Ph.D.s

Posted about 8 years ago

All events, groups, organizations, and centers are open for full participation by all individuals regardless of race, color, religion, sex, national origin, or any other protected category under applicable federal law, state law, and the University's nondiscrimination policy.

myUMBC is a UMBC limited public community forum for information sharing and dialogue. As a public institution, UMBC generally may not limit a community member's right to free speech on this forum. UMBC does not endorse the views expressed or information presented here, unless specifically stated in an official UMBC post. Learn more...

#6133 - DEV - development - dev - general-public